Description automatically generated


Local company first to produce Australia’s rarest and highest-grade Manuka honey

Varsity Lakes-based company manuka honey have successfully honed-in on the best hives and processes to produce Australia’s highest-grade Manuka honey. 

Possessing a powerful potency hundreds of times to that of the average Manuka, Biosota’s offering clocks out at 2000+ MGO (methylglyoxal) and is standing out as some of the best in the world.  

MGO is one of the key beneficial properties of Manuka honey and is what makes it so special, the higher the MGO, the higher the purity of honey and its associated health benefits. 

Biosota Founder Andrey Zubko says Manuka honey is the rarest of its kind and represents only one percent of all kinds of honey, making it extremely coveted.  

“Manuka honey is champagne in the world of honey and can only be created in very few locations across the east-coast of Australia and New Zealand where leptospermum trees are located,” says Mr Zubko.

“Achieving these extremely high grades and quality requires specific scientific and industry knowledge and careful collection.

“Biosota is fully committed to organic, sustainable and ethical best practices to produce our unique and high-grade Manuka honey.”

Biosota’s cutting edge techniques and stringent testing processes have assisted the company in reaching the 2000+ MGO status, as well as their commitment to the care of the environment and the health of their bees.

Produced locally, the third-generation beekeeping family has developed processes that support the health and survival rate of bees. 

“The health and happiness of our bees and their surrounding natural environment has always been our number one priority,” says Mr Zubko.

“As a result, we’ve produced the highest MGO Manuka honey in the world, ranging from 1200+ to 2000+.” 

Achieving high levels of MGO depends on two factors – the species of leptospermum flowers and the production and storge process. 

Honey must mature for 12 months following extraction and it is essential to do so at the right temperature. 

The process of accomplishing maximum maturity is when DHA (Dihydroxyacetone) converts to MGO. When the ratio becomes 1:1, the MGO has completed ageing. 

Biosota’s MGO 2000+ comes from Leptospermum Whitei, which has a lower glucose and fructose ratio, so it remains liquid. 

New Zealand Manuka (Leptospermum scoparium) has a high glucose and fructose ratio and therefore crystallises very easily. 

As honey crystallisation is due to the presence of glucose, New Zealand Manuka honey companies cream their honey so there are many small glucose crystals rather than fewer large crystals. 

Biosota’s Manuka honey is certified-organic, raw, not heat-treated and has been laboratory tested to ensure its potency, purity and quality. 

The company’s Manuka farm yields a unique microclimate, away from main roads and pollutants, making the product 100 per cent certified organic. 

Manuka honey’s purported benefits include wellbeing advantages with gut health, immunity, oral care, healthier skin and more. 

Biosota Organics Premium Australian Manuka Honey:

Family-owned, Biosota Organics produces a range of organic Australian Manuka honey containing the highest rated MGO levels in the world: 

MGO 1717+ is a hundred times more potent than the average Manuka honey

MGO 2000+ is the queen bee top-of-the range limited edition with only 500 jars available

Biosota Australian Manuka honey is single origin, traced from hive to jar, independently laboratory tested and certified 100% organic and non-GMO.

All honey remains in its raw, unfiltered, unheated, and unpasteurised state and is cold extracted to retain the highest levels of MGO bioactivity.


Disclaimer: All statements made have not been evaluated by the FDA (U.S. Food & Drug Administration) or TGA (Australian Therapeutic Goods Administration). Products sold are not intended to diagnose, treat, cure, or prevent any disease. Any information provided is not a substitute for a face-to-face consultation with your physician and should not be construed as individual medical advice.

For all media enquiries contact Andrey Zubko on 1300 88 32 66